EUVIMEDEUVIMED entdecken
Crossref

Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia

Katie Battese Ellis, Nalayin Sathasivam, Michael Bonifacio iD, Ronald Benzie

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2023-10 · 63 (5) · 666-672

DOI: 10.1111/ajo.13605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2022-09. Verfasst von Katie Battese Ellis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genea, Sydney, New South Wales, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Illumina Inc. Melbourne, VIC, Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Combined first‐trimester screening (cFTS) for fetal anomalies involves maternal serum screening for biochemical markers and measurement of the nuchal translucency (NT) by ultrasound. Noninvasive prenatal screening (NIPS) analyses cell‐free DNA present in a maternal blood sample for presence of fetal chromosomal aneuploidies.

Aims

To compare NIPS with cFTS as frontline screening in a public hospital in Australia. Materials and methods Women were offered NIPS in addition to the usual cFTS routinely offered to all women at a public hospital in NSW, Australia. The cFTS sample was collected at ten weeks' gestation and the NIPS sample at 12 weeks' gestation at the ultrasound appointment.

Results

In a low‐risk population of 997 women, frontline NIPS had a screen‐positive rate of 0.5% (5/997) vs 4.2% (42/997) with cFTS. cFTS correctly identified one trisomy 21 case and one trisomy 18 case; however, there were two trisomy 18 false negatives. Of five positive NIPS calls, four were correctly identified as trisomy 21 (one) and trisomy 18 (three); there were no NIPS false negatives. Overall, the false‐positive rate with NIPS was 0.1% vs 4.0% by cFTS.

Conclusions

The lower screen‐positive rate with NIPS for common trisomies was a result of the significantly lower false‐positive rate with NIPS. Consequently, NIPS as first‐line screening, even if funded by the hospital, may provide cost savings. We believe NIPS should be used from ten weeks' gestation in conjunction with morphology ultrasound for routine first‐trimester prenatal management.

Schlagwörter

Stichwörter der Autor:innen

aneuploidyfirst trimestermaternal serum screening testsnoninvasive prenatal screeningnuchal translucency measurement

Autor:innen und Institutionen

  • Genea, Sydney, New South Wales, Australia.
  • Perinatal Ultrasound Unit, Nepean Hospital, Penrith, New South Wales, Australia.

ORCID-Profile: Michael Bonifacio

Förderung

  • Illumina Inc. Melbourne, VIC, Australia

Zitieren

APA

Battese Ellis, K., Sathasivam, N., Bonifacio, M., & Benzie, R. (2023). Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology, 63(5), 666-672. https://doi.org/10.1111/ajo.13605

Vancouver

Battese Ellis K, Sathasivam N, Bonifacio M, Benzie R. Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2023;63(5):666-672. doi:10.1111/ajo.13605

BibTeX
@article{BatteseEllis2023,
  author = {Battese Ellis, Katie and Sathasivam, Nalayin and Bonifacio, Michael and Benzie, Ronald},
  title = {Comparison of noninvasive prenatal screening with combined first‐trimester screening as a frontline screening approach for common trisomies in a public hospital in Australia},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2023},
  volume = {63},
  number = {5},
  pages = {666--672},
  doi = {10.1111/ajo.13605}
}
Kostenlos starten →